INGRAM CHALLENGING BAN

Representatives for Mark Ingram say the Saints running back did not test positive for a performance enhancing drug and is weighing options for challenging his four-game suspension.

Paul Bobbitt and David Jones of VIP Sports Management say Ingram was using a substance that is permitted by the NFL with a “proper use exemption.” Ingram’s agents did not specify which substance Ingram used.

The NFL’s drug policy does not merely ban performance enhancing drugs, but also certain legal substances that have been known to skew drug test results. The NFL announced Ingram’s suspension Tuesday.

l The Eagles have signed RB Matt Jones to a two-year contract. Jones was a thirdround pick by Washington in 2015. —AP